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A cDNA clone of about 2500 basepairswas prepared from the human osteosarcoma cellline U-2 OS by 
hybridizing with a v-sis probe. Sequence analysis showed that this cDNA contains the coding region for 
the PDGF-B chain. Here we report that the mitogen secreted by these osteosarcoma cells contains the 
PDGF-B chain and is probably a homodimer of two B-chains. 
Platelet-derived growthfactor 
1. INTRODUCTION 
Platelet-derived growth factor (PDGF) is the 
major mitogen in serum for connective tissue-
derived cells in culture (review [1]). The protein has 
an apparent Mr of 30 000 and is a dimer of two 
chains linked by disulfide bonds. Protein sequence 
analysis of PDGF from human platelets revealed 
the presence of two types of sequences [2,3], which 
are about 600Jo homologous (type A and B). Recent 
studies have demonstrated that the sequence of 
PDGF-B is almost identical with the transforming 
oncogene product p28v-~i~ of the simian sarcoma 
virus [2-7]. 
It has been proposed that the secretion of 
mitogenic factors by transformed cells is important 
in the establishment and maintenance of the 
transformed state. Human 6steosarcoma, 
fibrosarcoma and glioblastoma cells in culture 
have been shown to synthesize and release into 
their medium biologically active PDGF-like 
polypeptides [8-12]. These human malignant cells 
contain RNAs that hybridize to v-sis probes 
[10-14]. The c-sis locus is furthermore expressed in 
various endothelial cell cultures, developing 
human placenta, cultured arterial smooth muscle 
cDNA Oncogene (Tumor ce/1) 
cells and a number of T -lymphoid cell lines 
transformed by HTLV-1 or II [15-19]. 
To establish the identity of the PDGF-like 
mitogen secreted by the human osteosarcoma cell 
line U2-0S [14] to the sequence of PDGF-B we 
have cloned and sequenced part of the cDNA 
hydridizing with the v-sis DNA. 
2. MATERIALSAND METHODS 
2.1. Materials 
Restrietion endonucleases, T4 DNA ligase, 
5' -polynucleotide kinase, DNA polymerase I and 
the large fragment of DNA polymerase I (Klenow 
fragment) were purchased from Boehringer, 
Mannheim. RNase H and E. coli ligase were ob-
tained from BRL and AMV reverse transcriptase 
was from Stehelin. Terminal deoxynucleotidyl-
transferase, dNTPs and ddNTPs were from Phar-
macia P-L Biochemicals. Chloramphenicol, am-
picillin and tetracyclin were purchased from 
Sigma. [a-32P]dATP and [a-35S)dATP were ob-
tained from Amersham. E. coli strains SK and JM 
103 were used for transformation by pBR322 or 
M13 vectors, respectively. 
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2.2. Ce// culture 
Osteosarcoma cells (U-2 OS) were kindly provid-
ed by Dr B. Westermark (Uppsala, Sweden) and 
were grown as described [14]. 
2.3. Isolation of RNA and Northern blotting 
Total RNA was isolated from cells according to 
[20] and poly(A)+ RNA was selected by two 
passages over an oligo(dT)-cellulose column. 
For Northern blotting RNA was denatured for 5 
min at 65°C in 500Jo formamide, 2.2 M for-
maldehyde and 10 mM sodium phosphate, pH 7.0, 
and subsequently electrophoresed in 1.20Jo agarose 
slab gels containing 0.5 M formaldehyde. Transfer 
to nitrocellulose sheets was done as described [2I]. 
RNAs containing sis-related sequences were iden-
tified by hydridization with 1 x 106 cpm/ml 32P-
nick-translated 1.2 kb Pstl fragment (1 x 108 
cpm/ ,ug) of the retroviral transforming v-sis gene 
[4]. Hybridization was performed for 20 hat 65°C 
in a mixture containing 2 x SSC ( l x SSC = 
I50 mM NaCl, 15 mM sodium citrate, pH 7.0), 
I x Denhard's solution (O.IOJo SOS, O.IOJo 
(/) 
0 
N 
' :::l 
8.2-
1.1- ._ 
2.1-
o.e-
Fig.l. Northern blot analysis of RNA from U2-0S cells. 
I 0 pg RNA were separated by electrophoresis in agarose 
(cf. section 2), transferred to nitrocellulose sheets and 
hybridized with a 32P-labelled 1.2 kb Pstl v-sis cDNA 
fragment. Autoradiography was done for 7 days. On the 
left the molecular masses of RNA standards are given in 
kb. 
Na2P20,, 2 mM EDTA, 50Jo dextran sulfate and 50 
pg/ml denatured salmon sperm DNA). The 
nitrocellulose sheets were washed twice for I5 min 
at 65°C with 0.4 x SSC, 0.1 OJo SDS and 2 mM 
EDT A. sis-related transcripts were visualized by 
autoradiography using Kodak XAR-5 films and an 
intensifier screen at - 70°C for 5-7 days. 
2.4. Construction and screening of a cDNA 
library 
cDNA from poly(A)+ RNA from U-2 OS cells 
was synthesized according to [22,23] using 
oligo(dT)I2-I8 as a primer for the firststrand syn-
thesis. Double strand cDNA was size fractionated 
on a 1.50Jo low-melting agarose gel, cDNAs > 900 
base pairs were isolated as described [24], and 
tailed with (dG) residues. The (dG)-tailed cDNA 
was annealed to (dC)-tailed EcoRV cut pBR322 
and was used to transform E. coli strain 5K accor-
ding to [25,26]. About 160000 transformants were 
obtained from 23 ng cDNA. Transformants con-
taining sis-related sequences were identified by col-
ony hydridization [22]. For hybridization 2 x 106 
cpm (I x 108 cpm/,ug) nick-translated v-sis probe 
was applied per 132 mm diameter nylon filter in 
2 x SSC at 65°C for II h. Filters were washed at 
65°C with a final wash in 0.20Jo SSC. 
Autoradiography was performed at -70°C with 
an intensifier screen for 1 day. 
2.5. DNA sequencing 
The l. 9 kb BamHI fragment from clone 
pMVW -2 containing the v-sis homologous region 
was subcloned into BamHI-digested Ml3mpl8 
[27]. After digestion with Pstll Sa/I the RFDNA 
was shortened with exonuclease 111 as described 
[28]. RFDNA was then sequenced in one direction 
from multiple overlapping subclones [29,30] using 
specific oligonucleotide primers. 
3. RESULTS 
A prominent v-sis hybridizing band of about 3.8 
kb was detected in polyadenylated RNA from 
cultured human osteosarcoma cells U-2 OS (fig.l ). 
This band is of similar size to RNA species isolated 
from various other celllines including cultured en-
dothelial cells [I O-I5]. In contrast to previous 
reports [10] we could detect only a single band in 
Northern blots. Smaller species of about 2.7 kb 
were missing. 
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o~------------------------1r-k_b _______________________ 2~kb __________ ~2.Skb 
Open Read1ng Frame 
pBR 322 BamHI 
--s·~~r---~~---.----------~----------~--~--------~------------~--~3 
Bam HJ Bgl II Neo I Neo I Bcrn Hl 
v- sas Homology 
----------------· -~---. 
PDGF Homolog y 
pMVW-2 
c -SIS cONA clone 
Fig.2. Restrietion map of the c-sis cDNA clone pMVW-2. The thick, double-ended arrow represents the c-sis cDNA 
insert in pMWV -2. The insert is flanked on the left and right by restriction sites from the vector pBR322. The v-sis 
and PDGF-B homologous regions are indicated by bold arrows. The small arrows running from right to left indicate 
the fragments used for M 13 sequencing. 
A cDNA library was constructed with the vector 
pBR322 using polyadenylated RNA from the cell 
line U-2 OS. Clone pMVW -2 was isolated using a 
v-sis probe [ 13]. The organization and restriction 
map of this clone is shown in fig.2. In this clone a 
2.5 kb polyadenylated cDNA fragment is inserted 
into the EcoRV site of pBR322. 
The sequence of the large BamHI fragment is 
shown in fig.3. A v-sis homologaus region extends 
from nucleotide 1 to I 034. In this region a stretch 
from nucleotide 682 to 828 is present which is not 
homologaus to v-sis. This is most likely due to the 
utilization of a different splice acceptor site in the 
human cells from which the cDNA was obtained 
compared to the wooly monkey cells from which 
simian sarcoma virus was originally isolated. A 
long uninterrupted reading frarne is present from 
nucleotide I to 648 including the stop codon TAG. 
Within this reading frame a stretch is located 
whose predicted amino acid sequence is identical 
with that of the PDGF-B chain with the exception 
of two positions. These two positions differing 
from the protein sequence of PDGF-B have been 
interpreted to reflect variants [7]. 
The sequence coding for the PDGF-B chain was 
identical to that of normal human c-sis gene 
[5-7, 15] and to the corresponding region in the 
plasmid pSM-1 from HUT 102 cells [16,17]. We 
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found some differences in the 31 -noncoding 
region. The reason for these minor alterations is 
unclear and might be due to small differences be-
tween species. 
4. DISCUSSION 
We have cloned a 2.5 kb fragment of the 3.8 kb 
mRNA hybridizing with the v-sis probe. Our 
studies establish that this 3.8 kb mRNA specifical-
ly expressed in various virally or nonvirally 
transformed tumor cells (e.g. osteosarcoma, 
fibrosarcoma, gliablastoma cells) contains the 
coding region for the precursor of the PDGF-B 
chain. Since our clone does not extend far enough 
to the 5 1 -region to cover a possible start codon we 
can make neither judgements about the fulllength 
of the PDGF-B precursor nor any Statements as to 
whether PDGF-A is also encoded on this long 
mRNA. On the other hand, the DNA sequences 
from HUT 102 cells and from human endothelial 
cells are almost identical with the sequence from 
U-2 OS cells and it is thus reasonable to assume 
that translation will start from the identical posi-
tion yielding a preproPDGF-B of 27 281 Da. 
There are no coding regions for PDGF-A in the 
3 '-flanking regions of pMVW-2 or in pSM-1 
(HUT 102 cells), nor are there any coding regions 
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PRO GtU GLU LIU TYR G~U MIT LIU $IR ASP RlS SIR ILB ARG SIR PBI ASP ASP LIU GLI 
1- 60 lc c c 9 a 9 9 a 9 clt t t • t 9 a 9 a tl9 c t 9 a 9 t 9 a clc a c t c 9 a t c Cl9 c t c c t t t 9 alt 9 a t c t c c a •I 
ARG LEU LBU BIS GLY ASP PRO GLY GLU GLU ASP GLY ALA GLU LIU ASP LIU ASB BIT TBR 
61- 1ZO lc 9 c c t 9 c t 9 cl• c 9 9 • 9 • c c clc 9 9 • 9 • 9 9 • •19 • t 9 9 9 9 c c 91• 9 t t 9 9 • c c tlr • t 9 • c cl 
ARG SIR BIS SIR GLY GLY GLU LIU GLU SIR LIU ALA ARG GtY ARG ARG SIR LEU GLY SIR 
121- 110 lc 9 c t c c tlc t 9 9 • 9 9 c 9 •19 c t 9 9 a 9 a 9 clt t 9 9 c t c 9 t 919 • • 9 • • 9 9 a 9lc c t 9 9 9 t t c cl 
LIU TBR ILI ALA GLU PRO ALA XBT ILE ALA GLU CYS LYS THR ARG YBR GLU VAL PBB GLU 
111- 240 lc t 9 a c c a t t 9lc t 9 a 9 c c 9 9 clc • t 9 a t c 9 c cl9 • 9 t 9 c a • 9 •lc 9 c CJ c • c c 9 •19 9 t 9 t t c 9 • 91 
ILB SIR ARG ARG LIU lLB ASP ARG THR ASR ALA ASR PHI LIU VAL TRP PRO PRO CYS VAL 
241- 300 I• t c t c c c 9 9 c 19 c c t c a t a 9 •I c c 9 c • • c 19 c c t t c c I t 9 9 t 9 t 9 9 c c 19 c c c t 9 t 9 t 91 
GLU VAL GLB ARG CYS SIR GLY CYS CYS ASR ASI ARG ASH VAL GLB CYS ARG PRO TBB GLB 
l o 1- 360 19 a 9 9 t 9 c • 9 c I CJ c t 9 c t c c 9 91 c t 9 c t 9 c • • c I• • c c 9 c • • c 91 t 9 c • 9 t 9 c c CJ I c c • CJ I 
VAL GLB LIU ARG PRO VAL GLR VAL ARG LYS ILE GLU ILB VAL ARG LYS LYS PRO ILB PBI 
361- 420 19 t 9 c • 9 c t 9 cl9 a c c t 9 t c c •19 9 t 9 • 9 • • • 91• t c 9 • 9 • t t 9lt 9 c 9 9 • • 9 • •19 • t c t t tl 
LYS LYS ALA TBR VAL TRR LEU GLU ASP BIS LEU ALA CYS LYS CYS GLU TBR VAL ALA ALA 
421- 410 I• a 9 a a 9 q c c •lc CJ 9 t CJ a c 9 c tiCJ CJ a a 9 • c c a clc t CJ 9 c • t q c •I• 9 t CJ t 9 a 9 • cl• 9 t 9 9 c a 9 c tl 
ALA ARG PRO VAL THR ARG SIR PRO GLY GLY SIR GLI GLU GLI ARG ALA LYS THR PRO GLB 
411- !U o 19 c a c 9 9 c c t 91 t 9 c 9 a a 91 c c c 9 9 9 9 9 9 t I t c c c • 9 9 • 9 c I• 9 c 9 • 9 c c • •I• • c 9 c • • I 
TBR ARG VAL THR ILE ARG THB VAL ARG VAL ARG ARG PRO PRO LYS GLY LYS BIS ARG LtS 
541- 600 I• c t c 9 9 9 t 9 •lc c a t t c 9 9 • <:19 9 t 9 c 9 a 9 t c1c 9 c c 9 9 clc c • • 9 9 9 c • &19 c 9 9 •I 
PHI LtS BIS TKR BIS ASP LYS THB ALA LEU LYS GtU TBR LEU GLY ALA 
601- 660 lt t c a a 9 c a c •lc 9 t 9 a •ICJ a F 9 9 c • c t 91& a 9 9 a 9 a c c clt t 9 9 • 9 t •19 9 9 9 e • t e 9 91 
661- 720 lc • 9 9 • 9 a 9 t 9lt 9 t 9 9 9 c • 9 919 t t • t t t a • tl• t 9 9 t • t t t 91" t 9 t a t t 9 c elc c c • t 9 9 9 9 c) 
721- 710 lc t t c 9 9 & 9 •• ~ •• 91• t t a t t 9 tlt t c:: c c t c g t c)c g t c t 9 t c t cl9 • t 9 c c t 9 • tlt c 9 9 9 9 c c I 
711- 840 I• a t 9 9 t 9 c t tlc c c a c c c:: clt 9 t 9 t c)c 9 t • c c c tlt c c. t c::. 9 c 919 9 t c t c:: c t c c::l 
141- 900 lc a 9 c '1 9 t clc 9 9 9 c t c t t 9lc c c • 9 c • 9 c tlc • • 9 • • 9 & & •I• a 9 • • 9 9 • c tl9 • • c t c t c I 
1101- 960 19 a t c t t c tlt c c c t t a a c tlc • 9 "t tl9 9 9. t •• g. 9lt 9 t 9 • 9. 9. 91& c t 9. t 9 9 9 91 
961-1020 lt c 9 c t c t t t 919 9 9 9 • • a c: 9 919 t c c t t c c c clt 9 c t 9 9 clc t 9 9 9 c c • c •lc c t 9 • 9 c 9 e tl 
1021-1010 19 t 9 9 t 9 t clc t g • 9 9 a 9 c clc t 9 • 9 9 a c c tlc t c a 9 c a t • 9IC c t 9 c c t 9 • tlc c c t 9 • c c I 
1011-1140 lc t 9 9 c c a 9 c: tlc t 9 a 9 9 9 9 a 919 c a c c t • 919 c • 9 9 c c a 9 91<: c a 9 9 c t 9 c clt c 9 9 a c t c e •I 
1141-1200 lt 9 9 c t a a 9 a clc • 9 • c 9 9 9lc • • 9 tl9 9 • 9 •• c clc c t c c c a c 9 9lt 9 c • a e •I 
1201-1260 le 9· t c a c c tlc 9 t c t t 919 t 9 c c t c t 9 t19 • 9 t 9 9 clt t c t t t t c 9 tlt t t c 9 t t t t 91 
1261-1320 I• a 9 a c 9 t 9 9 alc t c c t c t t 9 tlt 9 9 9 t 9 t 9 9 clc • 9 c • c •I• t 9 9 c t 9 9 9 t19 c c c t c t c • 91 
1321-1310 19 t 9 9 9 t t a 9 •19 • t 9 9 • 9 t t tl9 c t 9 t t q • 9 9lt 9 9 c t 9 t • 9 alt 9 9 t 9 a c c t 919 9 t • t c c tl 
1311-1440 19 c c t c c t 9 c cl• c c c c t t tlc c c c a c a c t clc a c t c t g a t t)c t c t t c clt c t 9 9 t t c c tl 
1441-1500 lt t c a t c t c t clt c t c c • c clc t 9 c a t t t t clc t c t t 9 t c c t)9 9 c c c t t c • 9lt c t 9 c t • c: I 
1501-1560 lc a a 9 9 9 9 c t clt t 9 a a c c c c tlt • t t • • 9 9 c clc c • 9 • t 9 • t clc e • 9 t c • c t cle t c t c t • 9 9 91 
1561-1620 lc a 9 a a 9 a c t •19 • 9 9 c c a 9 9 9IC a 9 c • a 9 9 9 alc c t 9 c t c a t cl• t • t t c c • & clc c • 9 c c IJ •I 
1621-1610 lc t 9 t 9 t •I• 9 9 t t 9 t 9 c •19 9 t 9 t 9 t tl9 c • 9 9 a cla t t 9 t • t 9 c •19 9 9 • 9 c t 91 
1611-1740 lt t c t c a tl• 9 a t a a a g c tl9 a t t t g t & t a)t t t • t t • t 9 •lc • • t t t c t 9 9IC • 9 • t 9 t • 9 91 
1741-1758 lt • 9 • 9 9 • •I• • 9 9 a t 
Fig.3. Sequence of the large BamHl fragment of the clone pMVW -2. The predicted amino acid sequence of the largest 
open reading frame is shown and the amino acid residues identical to those determined by protein sequence analysis 
for PDGF-B are underlined. Alterations in the DNA sequence from that of pSM-1 are indicated by dotted lines. 
in the 5 '-flanking regions of pSM-1 or pB2-l 
(human endothelial cells). It thus appears that the 
3. 8 kb mRNA detected by v-sis hybridization en-
codes only the PDGB-B chain. 
PDGF purified from human platelets contains a 
second polypeptide (PDGF-A) that is less 
homologaus to p28v-sis [2,3], and it has been pro-
posed that human PDGF is predominantly a 1:1 
disulfide-linked heterodimer of A and B chains 
[31,32]. On the other band, porcine PDGF seems 
to be a homodimer of two B-chains [33]. Our data 
favour the model that the mitogen secreted by the 
U-2 OS cells is a homodimer composed of B-
chains. But so far the genetic locus for the A-
chains has not been identified and it is unknown 
whether this locus is coexpressed with that for the 
B-chains. Assuming such a mechanism, the forma-
tion of heterodimers would be possible. 
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